As the new cases and related deaths fall in sub-Saharan Africa, the virus is rearing its head elsewhere. What’s the cause? And the solution?
HIV
Posted inNPR
This drug is the ‘breakthrough of the year’ — and it could mean the end of the HIV epidemic
That’s the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that prevents infection by the HIV virus.
Posted inNPR
‘America’s Nobel’ goes to a power couple who made a startling discovery about HIV
This year’s Lasker Prize for public service goes to South African researchers Salim and Quarraisha Abdool-Karim. The married couple made a startling discovery about HIV — and did something about it.
Posted inNPR
This preventive drug could be a ‘game changer’ in ending the HIV epidemic
In newly released data, lenacapavir, given via a twice-yearly injection, has shown remarkable effectiveness at eliminating HIV transmission during sexual contact. But its cost could be an issue.
Posted inNPR
One of the 7 people cured of HIV tells his story. Can his cure work for others?
The “Dusseldorf patient” spoke at last week’s AIDS 2024 conference in Munich. Here’s what doctors did — and what they say about their ability to replicate the procedure.
Posted inNPR
People with HIV are aging, and the challenges are piling up
Advances in medicine mean more people are living longer with HIV. But aging with HIV comes with increased health risks, and this growing population needs specialized care that’s hard to find.
Posted inArticle, Health
Rhode Island Cuts Funding To AIDS Group
The state has cut more than one million dollars to a nonprofit that helps people diagnosed with HIV and AIDS. The group has been forced to make some changes.